IC
EDIT icon

IEQ Capital’s Editas Medicine EDIT Stock Holding History

IEQ Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$706K Buy
217,785
+20,367
+10% +$59.5K ﹤0.01% 1253
2026
Q1 		$488K Buy
197,418
+108,225
+121% +$229K ﹤0.01% 1320
2025
Q4 		$183K Sell
89,193
-61,474
-41% -$177K ﹤0.01% 1709
2025
Q3 		$523K Sell
150,667
-3,857
-2% -$10.8K ﹤0.01% 1271
2025
Q2 		$340K Sell
154,524
-5,846
-4% -$9.56K ﹤0.01% 1333
2025
Q1 		$186K Buy
160,370
+135,736
+551% +$200K ﹤0.01% 1394
2024
Q4 		$31.3K Buy
+24,634
New +$62.8K ﹤0.01% 1308

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

IEQ Capital's EDIT Position: Q2 2026 in Review

IEQ Capital increased its Editas Medicine (EDIT) stake by 10% in Q2 2026, buying an estimated $59.5K and bringing the position to 217,785 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

IEQ Capital first reported a position in EDIT in Q4 2024 and has held it in 7 quarters since. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • IEQ Capital held 217,785 shares of Editas Medicine worth $706K as of Q2 2026.
  • IEQ Capital bought 20,367 Editas Medicine shares in Q2 2026, an estimated $59.5K.
  • Editas Medicine made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1253 holding.
  • IEQ Capital first reported a position in Editas Medicine in Q4 2024 and has held it in 7 quarters since.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.